In New York City, the prevalence of asthma among children entering school varies by neighborhood anywhere from 3% to 19%, and children growing up within walking distance of each other can have 2-3 fold differences in risk ...
May 17, 2011
0
0
A study appearing in MedComm has been led by Dr. Jizong Zhao, Dr. Dong Zhang, and Dr. Peicong Ge (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University and Department of Neurosurgery, Beijing Hospital). ...
Apr 18, 2024
0
6
Any changes in your medications or allergies? Check. New health issues since your last visit? Check.
Dec 4, 2023
0
1
Metagenomic sequencing can provide rapid and actionable antimicrobial resistance predictions to treat bloodstream infections much faster than conventional laboratory tests, and has the potential to save lives and better manage ...
Apr 17, 2023
0
12
Researchers from A*STAR's Institute of Bioengineering and Bioimaging (IBB), in collaboration with Changi General Hospital (CGH) and Lucence, a local biomedical start-up, conducted the first local prospective study which demonstrated ...
Jul 29, 2022
0
1
A potential new approach to administering an existing Japanese encephalitis (JE) vaccine could make it more affordable and increase dose numbers in Australia.
Apr 1, 2022
0
2
A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk prostate cancer will respond to treatment with radiation and hormone therapy. The study, which examined biopsy samples collected ...
Oct 25, 2021
0
3
The National Institutes of Health has started a Phase 1/2 clinical trial in which adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of different COVID-19 vaccines to determine the ...
Jun 2, 2021
0
1
An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95 percent accuracy, according to a new study from researchers ...
Jun 1, 2021
0
1
Next-generation sequencing (NGS) of cell-free DNA (cfDNA) obtained from blood samples may improve diagnostic testing in patients with advanced NSCLC, and may also be faster and less expensive compared to standard tissue profiling, ...
Oct 2, 2020
0
1
